Final talks on the Pathogen Access and Benefit-Sharing (PABS) system, the last outstanding piece of the Pandemic Agreement, are being held in Geneva this week. The Pandemic Agreement, being negotiated in Geneva, emerged to address the unacceptable inequities that defined the COVID-19 global health disaster. During this pandemic, delayed and inequitable access to vaccines may […] Continue reading ->
Following the lead of Australia, France, and Spain, Germany’s governing parties have found common ground on a proposal to ban social media for children. But as politicians prepare strict age restrictions, experts warn that significant legal roadblocks and data protection concerns could stall the legislation. At a recent party conference in Stuttgart, the centre-right Christian […] Continue reading ->
As the mandate of Dr Tedros Adhanom Ghebreyesus approaches its expiration in August 2027, the high-stakes manoeuvring for the next Director-General (DG) of the World Health Organization (WHO) has intensified in the halls of Geneva and capital cities worldwide. While the official call for nominations is expected in April 2026 and no candidate has formally […] Continue reading ->
The European Commission intends to significantly cut its contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria, ending a decades-long trend of increasing contributions to the multilateral health organisation. According to research by Health Policy Watch, the Commission plans to pledge €700 million over a four-year span from 2026 to 2029 at the […] Continue reading ->
Although Argentina is withdrawing from the World Health Organization’s global body, it intends to remain an active member in WHO’s regional affiliate, the Pan American Health Organization (PAHO),  the country’s representative told the WHO Executive Board on Friday.  His comments came in the course of a discussion on the legal and policy impacts of Argentina’s […] Continue reading ->
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […] Continue reading ->